Hepatitis Testing/Diagnosis Market Is Anticipated To Reach Up To USD 4.4 Billion By 2031

Market Definition

The goal of hepatitis diagnosis is to identify the genotype of the infection that is causing the condition. The optimal course of treatment for the patient can be chosen based on the hepatitis diagnosis.

Market Outlook

The global hepatitis testing/diagnosis market was valued at USD 2.6 billion in 2021 and it is anticipated to reach up to USD 4.4 billion by 2031, at a CAGR of 5.5% during the forecast period.

The goal of hepatitis diagnosis is to identify the genotype of the infection that is causing the condition. The optimal course of treatment for the patient can be chosen based on the hepatitis diagnosis. In order to distinguish between different hepatitis viruses, it is crucial to make a diagnosis of the illness. Inflammation in the liver is the primary cause of hepatitis. Different forms of the hepatitis virus, including Hepatitis A, B, and C, are recognized. Blood tests are used to identify the presence of hepatitis disease. Testing bodily proteins or genetic material that is a component of the virus can also be used to identify hepatitis.

Despite substantial advancements in treatment options, immunization coverage, and public awareness, hepatitis remains a serious public health concern with a high prevalence rate worldwide. The most common hepatitis forms, B and C, are associated with greater fatality rates. According to estimates, 296 million and 58 million persons, respectively, had chronic HBV and HCV infections in 2019. Compared to industrialized countries, hepatitis is more common in poor nations. Similarly, the biotechnology and biopharmaceutical industries have a significant demand for immunoassay equipment and supplies. Therefore, over the forecast period, the expansion of these industries is anticipated to boost the expansion of the hepatitis testing market. The expansion of the end-user market in these sectors has prompted numerous businesses to introduce new products and make investments in the development of cutting-edge products. Since immunoassays are used throughout the production process, from product development and manufacturing to quality control, this is regarded as a promising sign for the market's expansion.

To Know More https://www.globalinsightservices.com/reports/sterilization-equipment-market/?utm_id=1017

Research Objectives

Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
Identify factors influencing market growth and challenges, opportunities, drivers and restraints
Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Sample: https://www.globalinsightservices.com/request-sample/GIS10295/?utm_id=1017

Global Hepatitis Testing/Diagnosis Market Segmental Overview

The report analyses the global hepatitis testing/diagnosis market based on disease type, technology, end user, and region.

Global Hepatitis Testing/Diagnosis Market by Type

Based on the type, it is segmented into hepatitis B, hepatitis C, and other hepatitis. The hepatitis B segment dominated the hepatitis testing market in 2021. Hepatitis B is becoming more common, there are more hepatitis B diagnostic tests available, and more people are using nucleic acid tests to diagnose HBV, which is what is fueling the growth of this market segment.

Global Hepatitis Testing/Diagnosis Market by Technology

Based on the technology, it is segmented into enzyme-linked immunosorbent assay, rapid diagnostic tests, polymerase chain reaction, isothermal nucleic acid amplification technology, and other technologies. The ELISA segment to witness the highest market share during the projection period. The substantial proportion of this market is primarily due to the widespread use of this test to identify hepatitis in clinical settings.

Global Hepatitis Testing/Diagnosis Market by End User

Based on the end user, it is segmented into hospital & diagnostic laboratories, blood banks, and other end users. The hospital & diagnostic laboratories segment is anticipated to witness the fastest growth during the forecast period. The key factors such as high burden of hepatitis coupled with increasing blood transfusion and donations are boosting the growth of the segment in the market.

Request Customization: https://www.globalinsightservices.com/request-special-pricing/GIS10295/?utm_id=1017

Major Players in the Global Hepatitis Testing/Diagnosis Market

The key players studied in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), bioMérieux SA (France), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (US), MedMira Inc. (Canada), and Fujirebio US, Inc. (Japan) among others.

Request Discounted Pricing https://www.globalinsightservices.com/request-customization/GIS10295/?utm_id=1017

Research Scope

Scope - Highlights, Trends, Insights. Attractiveness, Forecast
Market Sizing - Product Type, End User, Offering Type, Technology, Region, Country, Others
Market Dynamics - Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
Business Framework - Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
Competitive Landscape - Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
Company Profiles - Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
Market Size in 2021 - US$ 2.6 Billion
Market Size in 2031 - US$ 4.4 Billion
CAGR % - 5.5%
Historic Period - 2015-2020
Forecast Period - 2022-2031
Base Year - 2021

Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10295/?utm_id=1017

About Us

With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Infographic excel data pack, easy to analyze big data
Robust and transparent research methodology
Unmatched data quality and after sales service

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.